GelMEDIX, Inc.
Injectable hydrogel scaffolds for retinal cell and gene therapy delivery
- Sector
- Biotech
- Headquarters
- CAMBRIDGE, MA
- Founded
- 2020
- Latest Form D
- $397K, Oct 2025
- Total capital
- $3.5M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $3.5M
- 4 Form D · last Oct 2025
- 12 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 14 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 4th filing$397K
- Private capital raisedForm D · SEC · 3rd filing$1M
- Private capital raisedForm D · SEC · 2nd filing$1.9M
- Private capital raisedForm D · SEC · 1st filing$250K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Arthur DriscollExecutive Officer, DirectorNamed in SEC Form D filings
- Jeffrey BehrensExecutive Officer, DirectorNamed in SEC Form D filings
- Max CotlerExecutive OfficerNamed in SEC Form D filings
- Michael CimaDirectorNamed in SEC Form D filings
- Nasim AnnabiDirectorNamed in SEC Form D filings
- Parinaz MotamedyDirectorNamed in SEC Form D filings
Show all 7 people
- Reza DanaDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 14- PendingGelma Polymer Compositions Comprising CellsUSPTOApplication 18857683
- PendingGelma Polymer Compositions And Uses ThereofUSPTOApplication 18248044
- PendingGelma Polymer Compositions And Uses ThereofUSPTOApplication 18692227
Show all 14 patent records
- Gelma Polymer Compositions Comprising CellsAug 14, 2025 · Application 18857683Pending
- Gelma Polymer Compositions And Uses ThereofDec 5, 2024 · Application 18248044Pending
- Gelma Polymer Compositions And Uses ThereofNov 14, 2024 · Application 18692227Pending
- Gelma Polymer Compositions Comprising CellsApplication 63410041Pending
- Gelma Polymer Compositions And Uses ThereofApplication PCTUS2022076491Pending
- Gelma Polymer Compositions Comprising CorticosteroidsApplication PCTUS2022076495Pending
- Gelma Polymer Compositions Comprising CellsApplication 63332963Pending
- Gelma Polymer Compositions And Uses ThereofApplication PCTUS2021053693Pending
- Gelma Polymer Compositions And Uses ThereofApplication 63244615Pending
- Gelma Polymer Compositions Comprising CorticosteroidsApplication 63244619Pending
- Acrylated Gelatin Polymer Compositions Comprising CellsApplication PCTUS2024051735Pending
- Acrylated Gelatin Polymer Compositions Comprising CellsApplication 19579310Pending
- Acrylated Gelatin Polymer Compositions Comprising CellsApplication 63591315Pending
- Gelma Polymer Compositions Comprising CellsApplication PCTUS2023019141Pending
Related companies, and why
- Seneca Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- ABLi Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- ZBiotics CoSimilar federal contract value in Biotech · null in contracts
- Lead Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- AptamiR Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Trethera CorpSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .